Sorrento Therapeutics, Inc. (SRNE)

USD 0.0

(0.0%)

Net Debt Summary of Sorrento Therapeutics, Inc.

  • Sorrento Therapeutics, Inc.'s latest annual net debt in 2022 was 110.87 Million USD , down -44.82% from previous year.
  • Sorrento Therapeutics, Inc.'s latest quarterly net debt in 2023 Q2 was 137.85 Million USD , up 4.52% from previous quarter.
  • Sorrento Therapeutics, Inc. reported annual net debt of 200.91 Million USD in 2021, up 77.91% from previous year.
  • Sorrento Therapeutics, Inc. reported annual net debt of 112.92 Million USD in 2020, down -57.9% from previous year.
  • Sorrento Therapeutics, Inc. reported quarterly net debt of 137.85 Million USD for 2023 Q2, up 4.52% from previous quarter.
  • Sorrento Therapeutics, Inc. reported quarterly net debt of 110.87 Million USD for 2022 Q4, up 13.68% from previous quarter.

Annual Net Debt Chart of Sorrento Therapeutics, Inc. (2022 - 2003)

Historical Annual Net Debt of Sorrento Therapeutics, Inc. (2022 - 2003)

Year Net Debt Net Debt Growth
2022 110.87 Million USD -44.82%
2021 200.91 Million USD 77.91%
2020 112.92 Million USD -57.9%
2019 268.26 Million USD 312.99%
2018 64.95 Million USD 526.84%
2017 -15.21 Million USD 56.62%
2016 -35.08 Million USD -17.69%
2015 -29.8 Million USD 50.12%
2014 -59.75 Million USD -122.46%
2013 -26.86 Million USD -427.6%
2012 -5.09 Million USD -46.87%
2011 -3.46 Million USD 34.32%
2010 -5.27 Million USD -53.87%
2009 -3.42 Million USD -801.52%
2008 -380.46 Thousand USD -1638.93%
2007 -21.87 Thousand USD 0.0%
2006 - USD 0.0%
2005 - USD -100.0%
2004 9537.00 USD 0.0%
2003 9537.00 USD 0.0%

Peer Net Debt Comparison of Sorrento Therapeutics, Inc.

Name Net Debt Net Debt Difference
America Great Health 1.81 Million USD -6004.766%
Ampio Pharmaceuticals, Inc. -3.81 Million USD 3006.16%
Aridis Pharmaceuticals, Inc. 1.25 Million USD -8741.308%
Biora Therapeutics, Inc. 32.21 Million USD -244.156%
Bio-Path Holdings, Inc. -939 Thousand USD 11907.242%
Better Therapeutics, Inc. -860 Thousand USD 12991.86%
Calithera Biosciences, Inc. -23.78 Million USD 566.134%
Comera Life Sciences Holdings, Inc. 328.44 Thousand USD -33656.443%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 4.57 Million USD -2326.039%
Eloxx Pharmaceuticals, Inc. -5.82 Million USD 2004.001%
Evelo Biosciences, Inc. 3.19 Million USD -3366.854%
Evolutionary Genomics, Inc. 3.16 Million USD -3401.142%
Finch Therapeutics Group, Inc. 5 Million USD -2116.513%
Galera Therapeutics, Inc. 134.04 Million USD 17.287%
Innovation1 Biotech Inc. 179.15 Thousand USD -61786.687%
Kiromic BioPharma, Inc. 12.33 Million USD -798.57%
Molecular Templates, Inc. 707 Thousand USD -15581.754%
Navidea Biopharmaceuticals, Inc. 438.44 Thousand USD -25187.152%
NexImmune, Inc. -3.13 Million USD 3638.055%
Orgenesis Inc. 21.78 Million USD -408.952%
Panbela Therapeutics, Inc. 2.61 Million USD -4138.15%
Point of Care Nano-Technology, Inc. -498.00 USD 22263152.209%
PaxMedica, Inc. Common Stock -4.71 Million USD 2453.607%
Scopus BioPharma Inc. -124.57 Thousand USD 89098.595%
Statera Biopharma, Inc. 14.41 Million USD -669.054%
TRACON Pharmaceuticals, Inc. -7.59 Million USD 1559.584%
Trevena, Inc. 2.25 Million USD -4810.097%
Vaxxinity, Inc. 10.13 Million USD -994.256%
Vaccinex, Inc. -1.28 Million USD 8707.919%
Vicapsys Life Sciences, Inc. 344.44 Thousand USD -32087.919%
Viracta Therapeutics, Inc. 13.23 Million USD -737.45%
ZIVO Bioscience, Inc. 71.96 Thousand USD -153967.424%